G. Lennard Gold, M.D., F.A.C.P.; Bruce I. Shnider, M.D., F.A.C.P.; John J. Lynch, M.D.
This content is PDF only. Please click on the PDF icon to access.
In the early 1940's mechlorethamine, nitrogen mustard (HN2), became available for the treatment of human malignant disease. It was soon apparent that this agent was able to produce objective responses in patients with lymphomatous disease. After this advance in cancer chemotherapy, a variety of alkylating agents and other chemicals have become available for the treatment of malignant lymphomas.
In addition to the alkylating agents a new group of plant alkaloids are now available for the treatment of these diseases. Adrenal steroids may be helpful in the primary therapy of these diseases as well as helping to alleviate the hemologic disorders
Learn more about subscription options.
Register Now for a free account.
Gold GL, Shnider BI, Lynch JJ. Current Therapy of Malignant Lymphomas.. Ann Intern Med. 1965;62:1092–1093. doi: 10.7326/0003-4819-62-5-1092_3
Download citation file:
Published: Ann Intern Med. 1965;62(5):1092-1093.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only